arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Cannabis Bioscience International Holdings, Inc.

CBIH
Price unavailable
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
22 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Neutral
auto_awesome

Analytical Summary

Cannabis Bioscience International Holdings, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth -25.0%
Op. Margin None
ROIC 6.3%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.20
info Valuation on last close.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.21K
↓ -25.0%
Net Income Profit after all expenses
$-82.64K
↓ -8.3%
Operating Margin Operating profit as % of sales
-180.0%
↑ +41.8% 1th
FCF / Share Free cash flow per share
$-0.00
↑ +83.7%
Long-Term Debt Long-term obligations
$290.87K
— -0.1%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
97
Financial Health
70
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 22 quarters